Cargando…

Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era

COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saini, Jasleen, Kaur, Pritpal, Malik, Naveen, Lakhawat, Sudarshan Singh, Sharma, Pushpender Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier GmbH. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/ https://www.ncbi.nlm.nih.gov/pubmed/36162150 http://dx.doi.org/10.1016/j.micres.2022.127206

Ejemplares similares

Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications
por: Boparai, Jaspreet Kaur, et al.
Publicado: (2020)

Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
por: Yasmeen, Nusrath, et al.
Publicado: (2023)

The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
por: Shi, Jingru, et al.
Publicado: (2022)

Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria
por: Deslouches, Berthony, et al.
Publicado: (2020)

Phage–Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency
por: Liu, Chengxi, et al.
Publicado: (2022)

ICMR’s Antimicrobial Resistance Surveillance system (i-AMRSS): a promising tool for global antimicrobial resistance surveillance
por: Kaur, Jasmine, et al.
Publicado: (2021)

The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
por: Mwangi, James, et al.
Publicado: (2019)

Designing double-site lipidated peptide amphiphiles as potent antimicrobial biomaterials to combat multidrug-resistant bacteria
por: Lai, Zhenheng, et al.
Publicado: (2022)

Rationally Designed Antimicrobial Peptides Are Potential Tools to Combat Devastating Bacteria and Fungi
por: Váradi, Györgyi, et al.
Publicado: (2022)

Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era
por: Lin, Liming, et al.
Publicado: (2021)

The race for antimicrobials in the multidrug resistance era
por: Molina‐Santiago, Carlos, et al.
Publicado: (2017)

Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections
por: Hagras, Mohamed, et al.
Publicado: (2021)

Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic
por: Ali, Waqas, et al.
Publicado: (2022)

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2021)

Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic
por: Kumar, Vikram, et al.
Publicado: (2023)

Recombinant Helicobacter pylori Vaccine Delivery Vehicle: A Promising Tool to Treat Infections and Combat Antimicrobial Resistance
por: Dieye, Yakhya, et al.
Publicado: (2022)

Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria
por: Kirienko, Natalia V., et al.
Publicado: (2019)

Promising role of defensins peptides as therapeutics to combat against viral infection
por: Solanki, Subhash Singh, et al.
Publicado: (2021)

Combating Antimicrobial Resistance in the Post-Genomic Era: Rapid Antibiotic Discovery
por: Yang, Yuehan, et al.
Publicado: (2023)

P481 Antifungal vaccines: An alternative approach to combat multidrug resistance in the post-antibiotic era
por: Ahmad, Aijaz
Publicado: (2022)

Editorial: Single-cell tools to combat antimicrobial resistance
por: Xu, Jiabao, et al.
Publicado: (2023)

Repositioning of 8-hydroxyquinoline derivatives as a new promising candidate for combating multidrug resistant Neisseria gonorrhoeae
por: Lawung, Ratana, et al.
Publicado: (2018)

Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives
por: Hetta, Helal F., et al.
Publicado: (2023)

Towards Robust Delivery of Antimicrobial Peptides to Combat Bacterial Resistance
por: Drayton, Matthew, et al.
Publicado: (2020)

A Review on the Use of Antimicrobial Peptides to Combat Porcine Viruses
por: Pen, Guihong, et al.
Publicado: (2020)

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
por: Mulani, Mansura S., et al.
Publicado: (2019)

Dimerization of Antimicrobial Peptides: A Promising Strategy to Enhance Antimicrobial Peptide Activity
por: Lorenzon, Esteban N., et al.
Publicado: (2019)

Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections
por: Khairkhah, Niloofar, et al.
Publicado: (2023)

Drug Delivery Systems for the Oral Administration of Antimicrobial Peptides: Promising Tools to Treat Infectious Diseases
por: Deshayes, Caroline, et al.
Publicado: (2022)

Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
por: Pelfrene, Eric, et al.
Publicado: (2021)

Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance
por: Cascioferro, Stella, et al.
Publicado: (2020)

Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
por: Khan, Shahper N., et al.
Publicado: (2016)

Combating multidrug‐resistant Plasmodium falciparum malaria
por: Thu, Aung Myint, et al.
Publicado: (2017)

New Chalcone–Triazole Hybrids with Promising Antimicrobial Activity in Multidrug Resistance Strains
por: Pereira, Daniela, et al.
Publicado: (2022)

Antibiofilm assay for antimicrobial peptides combating the sulfate‐reducing bacteria Desulfovibrio vulgaris
por: Stillger, Lena, et al.
Publicado: (2023)

Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria
por: Lennard, Patrick R., et al.
Publicado: (2023)

Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018)

Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era
por: Dzuvor, Christian K. O., et al.
Publicado: (2022)

Attacins: A Promising Class of Insect Antimicrobial Peptides
por: Buonocore, Francesco, et al.
Publicado: (2021)

The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide
por: Teng, Qiu-Xu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r62b59ld2tq0kin6n92sm1pp4a